During the last session, Atyr Pharma Inc (NASDAQ:ATYR)’s traded shares were 2.36 million, with the beta value of the company hitting 0.82. At the end of the trading day, the stock’s price was $4.20, reflecting an intraday gain of 8.53% or $0.33. The 52-week high for the ATYR share is $4.66, that puts it down -10.95 from that peak though still a striking 66.19% gain since the share price plummeted to a 52-week low of $1.42. The company’s market capitalization is $373.82M, and the average trade volume was 1.46 million shares over the past three months.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

Atyr Pharma Inc (ATYR) registered a 8.53% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.53% in intraday trading to $4.20, hitting a weekly high. The stock’s 5-day price performance is 20.34%, and it has moved by 28.44% in 30 days. Based on these gigs, the overall price performance for the year is 133.33%. An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 34.28%. While earnings are projected to return 23.15% in 2025.

ATYR Dividends

Atyr Pharma Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Atyr Pharma Inc (ATYR) shares are Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund. Data provided on Jan 31, 2025 indicates that Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund owns about 7.85 shares. This amounts to just over 8.82 percent of the company’s overall shares, with a $32.97 million market value. The same data shows that the other fund manager holds slightly less at 6.62, or about 7.44% of the stock, which is worth about $27.8 million.